Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Mind Altering Conversations with Mauro Cavara, featuring Steven Fülle
Check out the FIRST episode of our podcast series, MIND ALTERING CONVERSATIONS! In this series, psychedelic science student Steven Fülle talks to Dr. Mauro Cavara about his research into psilocybin being used for pain management in fibromyalgia.
Watch it here!
Congratulations to the NEW Dr. Eline C. H. M. Haijen!
After successfully defending her PhD thesis entitled: “Exploring the Adult ADHD Treatment Landscape: From Current Practices to Psychedelic Microdosing and Novel Screening Approaches.” In her thesis, she looks at novel approaches of treating ADHD with LSD microdosing.
Watch the defense here!Congratulations to the NEW Dr. Elisabeth Prevete!
On successfully defending her PhD thesis ‘Mental Effects and Potential Therapeutic Use of Kratom/Mitragynine!’ This project was a joint venture between Maastricht University and Sapienza University of Rome. This is Elisabeth’s SECOND doctorate, she now holds an MD and a PhD! Congrats once again Elisbath on a great accomplishment!
Watch the defense here!
Meet our Department!
The scientists in our lab come from many countries and backgrounds, all with highly unique research abilities. Come meet the people that make up the Psychopharmacology Department.
Learn MoreParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Dr. Mauro Cavarra
Psychosomatics, Chronic Pain, Psychedelic-Assisted Psychotherapy
I am a psychotherapist, hypnotherapist and clinical trainer interested in understanding the connection between mind and body. At the Department I work in research projects that explore the potential of psychedelic therapies in the treatment...
Dr. Conny Quaedflieg
Intentional Forgetting, EEG, Stress Resilience
Through my extensive research experience, I have built expertise in various disciplines (psychology, psychophysiology, neurosciences) and I have become enthusiastic about bridging them.
Max Kaiser , MSc
I investigate whether inaccessible memories can be recovered and made retrievable again using various forms of non-invasive stimulation.
Zain Gangaram, MSc
My research is multifaceted and is based on an RDoC model for Reactive Aggression (RA).
Iva Totomanova, MSc
My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.
Dr. Malin Vedøy Uthaug
5-MeO-DMT, Consciousness, Ayahuasca
I am an altered states of consciousness researcher from Norway and one of the world leading experts on 5-MeO-DMT.
Dr. Pablo Mallaroni
Psychedelics, fMRI/MRS, Idiosyncracy
I am Postdoctoral Researcher with the Psychopharmacology Unit of Maastricht University with a background in translational neuroscience.
Dr. Lilian Kloft
Drugs, False Memory, Cognition
I am a postdoctoral researcher in the fields of psychopharmacology and forensic psychology with an international education from various high-class universities.
Dr. Johannes Reckweg
5-MeO-DMT, Neuropsychopharmacology, Therapy
I am Johannes, a PhD from Germany. After receiving my Bachelor’s degree from the Rijksuniversiteit Groningen, I came to Maastricht for my Master in Neuropsychology.
Psychedelic Research
Ritualistic use of ayahuasca enhances a shared functional connectome identity with others
Functional Connectivity, Ayahuasca, Ritual
→
Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions
visual, Psychedelics, vision, retinofugal, tripping, hallucinations
→
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
→
Microdosing with psychedelics to self-medicate for ADHD symptoms in adults: A prospective naturalistic study
→
Cannabis Research
Comparison of Cannabinoid Pharmacokinetic Properties in Occasional and Heavy Users Smoking a Marijuana or Placebo Joint
→
Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity
Glutamate, Functional Connectivity, Cannabis
→
Medicinal Δ9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.